FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 21 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $13,464,000 | +49.4% | 1,200,000 | 0.0% | 0.19% | +31.9% |
| Q3 2023 | $9,012,000 | -14.9% | 1,200,000 | 0.0% | 0.14% | -2.1% |
| Q2 2023 | $10,596,000 | +6.1% | 1,200,000 | 0.0% | 0.14% | -2.7% |
| Q1 2023 | $9,984,000 | -13.3% | 1,200,000 | 0.0% | 0.15% | -14.0% |
| Q4 2022 | $11,520,000 | +18.5% | 1,200,000 | 0.0% | 0.17% | -4.4% |
| Q3 2022 | $9,720,000 | +43.4% | 1,200,000 | 0.0% | 0.18% | +34.3% |
| Q2 2022 | $6,780,000 | +0.9% | 1,200,000 | 0.0% | 0.13% | +8.9% |
| Q1 2022 | $6,720,000 | +27.3% | 1,200,000 | 0.0% | 0.12% | +36.7% |
| Q4 2021 | $5,280,000 | -66.4% | 1,200,000 | -28.1% | 0.09% | -63.6% |
| Q3 2021 | $15,731,000 | +29.2% | 1,670,000 | 0.0% | 0.25% | +16.5% |
| Q2 2021 | $12,174,000 | +17.4% | 1,670,000 | 0.0% | 0.21% | +18.4% |
| Q1 2021 | $10,371,000 | -16.6% | 1,670,000 | 0.0% | 0.18% | -16.4% |
| Q4 2020 | $12,442,000 | +22.9% | 1,670,000 | 0.0% | 0.21% | +48.6% |
| Q3 2020 | $10,120,000 | -27.4% | 1,670,000 | 0.0% | 0.14% | -47.8% |
| Q2 2020 | $13,945,000 | +112.3% | 1,670,000 | +51.0% | 0.28% | +24.3% |
| Q1 2020 | $6,570,000 | -8.3% | 1,105,999 | 0.0% | 0.22% | +5.7% |
| Q4 2019 | $7,167,000 | +34.7% | 1,105,999 | 0.0% | 0.21% | -5.4% |
| Q3 2019 | $5,320,000 | +20.3% | 1,105,999 | 0.0% | 0.22% | +45.1% |
| Q2 2019 | $4,424,000 | -17.5% | 1,105,999 | 0.0% | 0.15% | -34.1% |
| Q1 2019 | $5,364,000 | -24.0% | 1,105,999 | 0.0% | 0.23% | -45.0% |
| Q4 2018 | $7,056,000 | -15.9% | 1,105,999 | +8.1% | 0.42% | +9.6% |
| Q3 2018 | $8,386,000 | -21.6% | 1,022,666 | 0.0% | 0.38% | -6.6% |
| Q2 2018 | $10,700,000 | +225.8% | 1,022,666 | +275.1% | 0.41% | +162.4% |
| Q1 2018 | $3,284,000 | +20.5% | 272,666 | +32.4% | 0.16% | -11.3% |
| Q4 2017 | $2,726,000 | +272.9% | 206,000 | +209.0% | 0.18% | +210.5% |
| Q3 2017 | $731,000 | – | 66,666 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,056,000 | 0.85% |
| Southpoint Capital Advisors LP | 3,997,214 | $19,386,000 | 0.82% |
| 683 Capital Management, LLC | 971,351 | $4,711,000 | 0.43% |
| Avoro Capital Advisors LLC | 1,105,999 | $5,364,000 | 0.23% |
| Eventide Asset Management | 720,000 | $3,492,000 | 0.12% |
| Granahan Investment Management | 410,932 | $1,993,000 | 0.11% |
| Zebra Capital Management LLC | 17,568 | $85,000 | 0.04% |
| Hartford Financial Management Inc. | 12,300 | $60,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 84,750 | $411,000 | 0.01% |
| Wealthspire Advisors, L.P. | 9,500 | $46,000 | 0.00% |